Passer au contenu

/ Faculté de pharmacie

Je donne

Rechercher

Rami Al Batran

Vcard

Professeur adjoint

Faculté de pharmacie

Pavillon Jean Coutu local 3216

Courriels

rami.al.batran@umontreal.ca (Travail)

Travail 1 : 514 343-6111 #14500

Biographie

Dr Al Batran has extensive expertise in the areas of obesity and energy metabolism, as well as animal models of diabetes and cardiovascular disease. His ongoing research program primarily focusing on how obesity-induced alterations in energy metabolism, and how targeting energy metabolism may be a novel approach to counteract obesity-related diseases such as type 2 diabetes and cardiovascular disease.

Lire plus…

Affiliations

Recrutement recherche

PhD Position in Energy Metabolism

About the Lab

The Al Batran lab is looking for an enthusiastic and highly motivated PhD candidate who has a degree in Molecular Biology and/or Biotechnology. The laboratory is located at the Faculty of Pharmacy, University of Montreal, and the Lab offers an attractive and friendly research environment, provides state-of-the-art instrumentation and techniques.

Project Description

This position is available in the laboratory headed by Dr. Rami Al Batran. The project goal is focused on understanding how alterations in ketone body metabolism at the cellular and molecular levels contribute to obesity-related metabolic disorders including insulin resistance, type 2 diabetes, and diabetic kidney disease.

Qualification Requirements

  • Applicants must hold a master’s degree in Molecular Biology and/or Biotechnology.
  • To have obtained at least 3.3 out of 4 GPA of during his/her undergraduate studies.
  • Background and experience in some of the following areas is required: biochemistry, animal studies and cell culture.
  • Fluent oral and written communication skills in English and French.

Personal skills

The successful candidate will be:

  • Highly motivated to do world class research.
  • Self-driven and enthusiastic.
  • Able to work independently and in a structured manner.
  • Willing to learn new skills.
  • Proactive in solving problems.

How to apply

The application must include

  • Cover letter statement of motivation and research interests.
  • CV (summarizing education and list of laboratory experience).
  • Copies of educational certificates (academic transcripts only).
  • A complete list of publications and academic works.
  • List of reference persons: 2-3 references (name, relation to candidate, and e-mail).

These documents must be submitted before September 1, 2021. Only shortlisted candidates will be contacted during September 2021.

Contact information

Applicants should submit their files in one PDF to Dr. Rami Al Batran for further details.

Faculty of Pharmacy

University of Montreal 

E-mail: rami.al.batran@umontreal.ca

Website: https://www.albatranlab.com

Lire plus…

Programmes d’enseignement

  • Doctorat de 1er cycle en pharmacie – Sciences de la santé
  • Maîtrise en sciences pharmaceutiques, option médicament et santé des populations – Sciences de la vie
  • Maîtrise en sciences pharmaceutiques – Sciences de la santé

Cours donnés

  • PHA1140 Fonctionnement normal du corps humain 4
  • PHM6076 Lectures dirigées en sciences pharmaceutiques

Expertises

Projets de recherche Tout déplier Tout replier

Exploring the Hepatoprotective Actions of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Projet de recherche au Canada / 2024 - 2031

Chercheur principal : Rami Al Batran
Sources de financement : IRSC/Instituts de recherche en santé du Canada
Programmes de subvention : PVXXXXXX-(PJT) Subvention Projet

Investigating the Short- and Long-term Effects of Ketogenic Diet on Atherosclerosis Projet de recherche au Canada / 2023 - 2026

Chercheur principal : Rami Al Batran
Sources de financement : FMCC/Fondation des maladies du coeur du Canada
Programmes de subvention : PVXX7979-Subvention pour projet de recherche et de développement

Cibler le métabolisme des corps cétoniques dans l'obésité et le syndrome métabolique Projet de recherche au Canada / 2022 - 2026

Chercheur principal : Rami Al Batran
Sources de financement : FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Programmes de subvention : PVXXXXXX-Établissement de jeunes chercheurs Juniors 1

Cibler le métabolisme des corps cétoniques dans l'obésité et le syndrome métabolique Projet de recherche au Canada / 2022 - 2026

Sources de financement : FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Programmes de subvention : PVXXXXXX-Bourse de chercheur-boursier : Junior 1

Medium Chain Triglycerides and Ketogenesis Projet de recherche au Canada / 2020 - 2026

Chercheur principal : Rami Al Batran
Sources de financement : CRSNG/Conseil de recherches en sciences naturelles et génie du Canada (CRSNG)
Programmes de subvention : PVXXXXXX-(DGECR) Tremplin vers la découverte

Medium Chain Triglycerides and Ketogenesis Projet de recherche au Canada / 2020 - 2026

Chercheur principal : Rami Al Batran
Sources de financement : CRSNG/Conseil de recherches en sciences naturelles et génie du Canada (CRSNG)
Programmes de subvention : PVX20965-(RGP) Programme de subvention à la découverte individuelle ou de groupe

Investigating the Role of Ketone Body Metabolism in Diabetic Kidney Disease Projet de recherche au Canada / 2022 - 2025

Chercheur principal : Rami Al Batran
Sources de financement : KRESCENT Program The Kidney Foundation of Canada
Programmes de subvention :

Pharmacothérapie du métabolisme du corps cétonique dans l'obésité Projet de recherche au Canada / 2021 - 2025

Chercheur principal : Rami Al Batran
Sources de financement : FCI/Fondation canadienne pour l'innovation
Programmes de subvention : PVXXXXXX-Fonds d'exploitation des infrastructures (FEI)

Could a Ketogenic Diet Slow the Progression of Diabetic Kidney Disease? Projet de recherche au Canada / 2021 - 2024

Chercheur principal : Rami Al Batran
Sources de financement : Fondation canadienne du rein
Programmes de subvention :

Réseau de recherche en santé cadiométabolique, diabète et obésité CMDO / Quantitative fluxomics of ketone bodies in diabetic kidney disease (the identified trainee is Abdualrahman Abdualkader and the intercenter collaborator is Dr. Matthieu Ruiz (IRCM)). Projet de recherche au Canada / 2021 - 2024

Sources de financement : FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Programmes de subvention : PVXXXXXX-Réseaux thématiques de recherche

Branched-Chain Amino Acids and Insulin Resistance Projet de recherche au Canada / 2022 - 2023

Chercheur principal : Rami Al Batran
Sources de financement : Diabète Québec
Programmes de subvention :

Investigating the Role of Ketone Body Metabolism in Diabetic Kidney Disease Projet de recherche au Canada / 2022 - 2023

Chercheur principal : Rami Al Batran
Sources de financement : KRESCENT Program The Kidney Foundation of Canada
Programmes de subvention :

Pharmacothérapie du métabolisme du corps cétonique dans l'obésité Projet de recherche au Canada / 2020 - 2022

Chercheur principal : Rami Al Batran
Sources de financement : FCI/Fondation canadienne pour l'innovation
Programmes de subvention : PVXXXXXX-Fonds des leaders

Publications Tout déplier Tout replier

Selected Publications:

Al Batran R, Gopal K, Capozzi ME, Chahade JJ, Saleme B, Tabatabaei-Dakhili SA, Greenwell AA, Niu J, Almutairi M, Byrne NJ, Masson G, Kim R, Eaton F, Mulvihill EE, Garneau L, Masters AR, Desta Z, Velázquez-Martínez CA, Aguer C, Crawford PA, Sutendra G, Campbell JE, Dyck JRB, and Ussher JR. Pimozide Alleviates Hyperglycemia in Diet-Induced Obesity by Inhibiting Skeletal Muscle Ketone Oxidation. Cell Metabolism. 2020 https://doi.org/10.1016/j.cmet.2020.03.017

Eshreif A, Al Batran R, Jamieson KL, Darwesh AM, Gopal K, Greenwell AA, Zlobine I, Aburasayn H, Eaton F, Mulvihill EE, Campbell JE, Seubert JM, Ussher JR. L-citrulline supplementation improves glucose and exercise tolerance in obese mice. Exp Physiol. 2019 Dec 5. doi: 10.1113/EP088109.

Uddin GM, Zhang L, Shah S, Fukushima A, Wagg CS, Gopal K, Al Batran R, Pherwani S, Ho KL, Boisvenue J, Karwi QG, Altamimi T, Wishart DS, Dyck JRB, Ussher JR, Oudit GY, Lopaschuk GD. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovasc Diabetol. 2019 Jul 5;18(1):86.

Ho KL, Zhang L, Wagg C, Al Batran R, Gopal K, Levasseur J, Leone T, Dyck JRB, Ussher JR, Muoio DM, Kelly DP, and Lopaschuk GD. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency. Cardiovasc Res. 2019 Feb 18. pii: cvz045.

Al Batran R, Gopal K, Aburasayn H, Eshreif A, Almutairi M, Greenwell AA, Campbell SA, Saleme B, Court EA, Eaton F, Light PE, Sutendra G, Ussher JR. The antianginal ranolazine mitigates obesity-induced hepatic steatosis and increases hepatic dehydrogenase activity. JCI Insight. 2019 Jan 10;4(1). pii: 124643.

Al Batran R, Gopal K, Martin MD, Ho KL, Almutairi M, Aburasayn H, Eaton F, Campbell JE, Ussher JR. Skeletal muscle-specific Cre recombinase expression, controlled by the human α-skeletal actin promoter, improves glucose tolerance in mice fed a high-fat diet. Diabetologia. 2018 Aug;61(8):1849-1855.

Gopal K, Almutairi M, Al Batran R, Eaton F, Gandhi M, Ussher JR. Cardiac-specific deletion of pyruvate dehydrogenase impairs glucose oxidation rates and induces diastolic dysfunction. Front Cardiovasc Med. 2018 Mar 6; 5:17.

Al Batran R, Almutairi M, Ussher JR. Glucagon-like peptide-1 receptor mediated control of cardiac energy metabolism. Peptides. 2018 Feb;100:94-100.

Aburasayn H, Al Batran R, Gopal K, Almutairi M, Eshreif A, Eaton F, Ussher JR. Female offspring born to obese and insulin-resistant dams are not at increased risk for obesity and metabolic dysfunction during early development. Can J Physiol Pharmacol. 2018 Jan;96(1):97-102.

Al Batran R, & Ussher JR. Revisiting protein acetylation and myocardial fatty acid oxidation. Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H617-H619

Gopal K, Saleme B, Al Batran R, Aburasayn H, Eshreif A, Ho KL, Ma WK, Almutairi M, Eaton F, Gandhi M, Park EA, Sutendra G, Ussher JR. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression. Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H479-H490.  

Aburasayn H, Al Batran R, Ussher JR. Targeting ceramide metabolism in obesity. Am J Physiol Endocrinol Metab. 2016 Aug 1;311(2):E423-35.

Prix et distinctions


  • Research Scholars Junior 1 - Fonds de recherche du Québec - Santé (FRQS)


    KRESCENT New Investigator Award - A Joint Program Between KFC and CIHR


    Post-Doctoral Fellowship - Canadian Institutes of Health Research (CIHR / IRSC)


    Post-Doctoral Fellowship - Diabetes Canada

Consultez cette fiche sur :